HOME >> MEDICINE >> NEWS
Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD

SAN DIEGO May 23, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) today announced that VYVANSE (lisdexamfetamine dimesylate) effectively controlled Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children aged 6 to 12 years. In addition, 95 percent of children taking VYVANSE daily for 12 months showed overall improvement, according to phase III open-label extension trial results. Further analysis of phase II clinical data demonstrated that VYVANSE provided consistent time to maximum concentration of d-amphetamine from patient to patient. Both studies were presented today at the annual meeting of the American Psychiatric Association (APA).

The U.S. Food and Drug Administration (FDA) approved VYVANSE for the treatment of ADHD on Feb. 23, 2007. VYVANSE remains on track for commercial launch in June 2007.

"Our research concluded that patients taking a daily morning dose of VYVANSE for up to 12 months demonstrated consistent control in ADHD symptoms from month to month," said Robert Findling, M.D., lead investigator of the long-term open-label study and Professor of Psychiatry at Case Western Reserve University and Director of the Division of Adolescent and Child Psychiatry at University Hospitals Case Medical Center. "As the first prodrug stimulant, VYVANSE will provide a novel approach to the delivery of stimulant medication for the treatment of ADHD."

Long-term Treatment with VYVANSE Yields Significant ADHD Symptom Improvement

In the long-term open-label extension trial, patients taking VYVANSE showed a greater than 60 percent improvement in the symptoms of ADHD, based on the participants' average change in ADHD Rating Scale (ADHD-RS-IV) scores* from baseline, the primary endpoint, after one year of treatment. Specifically, mean scores decreased 63 percent from baseline (P <.0001). Additionally, 95 percent of patients who received 12 months of daily treatment were rated as "very much improved" or "mu
'"/>

Contact: Marion E. Glick
212-601-8273
Porter Novelli
23-May-2007


Page: 1 2

Related medicine news :

1. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
2. Long-term aspirin use associated with reduced risk of dying in women
3. Long-term data on safety and effectiveness of antiobesity drugs needed
4. Long-term financial costs associated with prostate cancer treatment
5. Long-term effects of non-alcoholic fatty liver disease
6. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
7. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
8. Long-term safety results released for breast cancer drugs
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 10, 2020 , ... The ... Certified Pediatric Emergency Nurse (CPEN) specialty nursing certification program has been reaccredited ... is a national board certification earned by registered nurses (RNs) who demonstrate advanced ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real World Evidence and Data:, ... 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata , How can one ... and identify gaps and challenges when conducting trials? The Tufts Center for the ...
(Date:1/7/2020)... ... January 07, 2020 , ... Midmark Corp., a leading provider ... that will significantly impact the point of care ecosystem, where the majority of ... provider and patient is the most important aspect of the healthcare journey. Medical, ...
(Date:1/7/2020)... YORK (PRWEB) , ... January 07, 2020 , ... Twenty-six ... a year-long Facebook fundraiser to help others living with YOPD attend the 6th World ... for two weeks, running back to back to cover all 52 weeks in 2020. ...
(Date:1/7/2020)... LOS ANGELES (PRWEB) , ... January 06, 2020 , ... ... found a correlation between weight loss surgery and fewer complications including high blood pressure ... who had bariatric surgery between their first and their second pregnancies were less likely ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... ... January 07, 2020 , ... ... Jan. 21, 2020, 11:00 a.m.-12:30 p.m. EST, https://www.fdanews.com/chinanpma , China is ... is the only market with a 20 percent annual growth rate year after ...
(Date:1/3/2020)... ... 02, 2020 , ... Fresh from his sold-out Fall 2019 biomimetic dentistry classes ... in cosmetic and biomimetic dentistry, is expanding his education and training offerings with a ... . , Dentists from around the world attend Dr. Nejad's sold-out classes to learn ...
(Date:1/3/2020)... ... January 03, 2020 , ... In Partnership with the ... for low-income, underinsured individuals at its Burleson, TX office on February 8th. , Dental ... , cleanings and extractions . For more information, please visit the ...
Breaking Medicine Technology:
Cached News: